Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds

Archives of Dermatology

Volumn 136, Issue 10, 2000, Pages 1225-1230

  Falabella, Anna F ^a,b   Valencia, Isabel C ^b   Eaglstein, William H ^b   Schachner, Lawrence A ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DEVICE; EPIDERMOLYSIS BULLOSA; FEMALE; GRAFT REJECTION; HUMAN; INFANT; INFECTION; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SAFETY; SKIN GRAFT; WOUND DRESSING; WOUND HEALING;

EID: 0033778843     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.136.10.1225     Document Type: Article

References (8)

1. Clinicopathologic types of epidermolysis bullosa and their non-dermatological complications
2. Vesiculobullous and neonatal diseases
3. Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa: A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry
4. Development of a bilayered living skin construct for clinical applications
5. The use of tissue engineered skin (Apligraf) to treat a newborn with epidermolysis bullosa
6. HLA-DQB1 and DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours
7. Rapid healing of venous ulcers and lack of clinical rejection with an allogenic cultured human skin equivalent
8. A composite skin substitute (graftskin) for surgical wounds